Open AccessThe Impact on COVID-19 by Intravenous Bevacizumab Used for Hereditary Hemorrhagic Telangiectasia: A Case Report
Author(s) -
Ryan Patrick Fanning,
Sara Strout,
Nicholas R. Rowan,
Clifford R. Weiss,
Panagis Galiatsatos
Publication year - 2022
Publication title -
journal of medical cases
Language(s) - English
Resource type - Journals
eISSN - 1923-4163
pISSN - 1923-4155
DOI - 10.14740/jmc3948
Subject(s) - medicine , bevacizumab , covid-19 , telangiectasia , pneumonia , pandemic , monoclonal , disease , intensive care medicine , pediatrics , infectious disease (medical specialty) , monoclonal antibody , pathology , immunology , antibody , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom